专肽生物_定制多肽合成服务_多肽合成定制服务_多肽合成厂家_多肽合成公司

Integrin Binding Peptide 衍生自纤连蛋白。Integrin Binding Peptide 可用于制备 PEG 水凝胶。
Integrin Binding Peptide is derived by fibronectin. Integrin Binding Peptide can be used for PEG hydrogel preparation[1][2].

RGD肽-说明

RGD肽是指含有由Arg-Gly-Asp三个氨基酸组成的序列多肽，有直线肽和环肽之分。它们是许多细胞外基质蛋白（如VN、FN、FGN、胶原等）等最小识别短肽序列。

研究发现，RGD序列肽具有广泛的生物活性，可用于心血管疾病、骨质疏松和炎症等疾病的治疗，还可以预防和治疗由细胞粘附异常而导致的肿瘤，尤其是发展性肿瘤的转移；另一方面，RGD 序列肽又可作为兴奋剂，促进损伤的器官与组织的再生、伤口的愈合等等，RGD作为某些整合素的受体，其选择性部分依赖于RGD的构象以及RGD周围的氨基酸残基。

为此，近几年，许多科技工作者合成了一系列RGD三肽、四肽、五肽等，还合成了RGD环肽、双线肽、RGD模拟肽等等。为了满足客户对各种RGD序列肽的需求，专肽生物提供最广泛的RGD序列肽库，以满足科研工作者对RGD肽的需求。

专肽生物提供各种RGD肽的现货，缩短科研工作者的项目时间，例如c(RGDfK)、c(RGDfC)、c(RADyK)、c(RGDyK)、c(RADfC)、环状多肽c(RGDfK)-巯基乙酸、c(RGDfK)-PEG2-巯基乙酸、Mpa-Ahx-c(RGDfK)、环状多肽c(RGDfK)-半胱氨酸、DOTA-c(RGDfK)、NOTA-c(RGDfK)、NOTA-c(RGDyK)、DOTA-c(RGDyK)、E[c(RGDfK)]2、E[c(RGDyK)]2、DDDDD-c(RGDfK)等等，具体可咨询销售人员。

Definition
The integrins are a superfamily of cell adhesion receptors that bind to extracellular matrix EMC ligands, cell-surface ligands, and soluble ligands.

Discovery
The discovery of integrins was driven in large part by a series of early observation suggesting that adhesion to ECM is mediated at the cell surface receptors. By 1980s, it became clear that fibronectin was one of the groups of ECM proteins present in the serum that could promote the adhesion of cells to the tissue culture flask. 

Structure of integrins
The integrins are a family of alpha, beta heterodimeric receptors. Integrins are expressed by all multicellular animals, but their diversity varies widely among species; for example, in mammals, 19 alpha and 8 beta subunit genes encode polypeptides that combine to form 25 different receptors, whereas the Drosophila and Caenorhabditis genomes encode only five and two integrin alpha subunits respectively.

The N-terminal portion of integrin a subunits comprises seven homologous, tandemly repeated domains of about 50 amino acids. Repeats 4-7 (or in some integrins 5-7) contain cation-binding sequences. Seven integrin a subunits (a1, a2, aE, aL, aM, aX, and aD) contain a domain of ~200 amino acids inserted between the second and third N-terminal repeats. This domain is homologous in sequence to the ‘A’ domains of von Willebrand factor, and has been shown to contain a single cation binding site1

The b ?subunit contains a region of ~240 amino acids near its N terminus that is highly conserved between different b subunits. This region may also have an A-domain-like structure with a cation binding site. The C-terminal portion of the b ?subunit contains a number of cysteine-rich repeats2.

Mechanism of action
Cell-cell and cell-substratum adhesion is mediated by the binding of integrin extracellular domains to diverse protein ligands; however, cellular control of these adhesive interactions and their translation into dynamic cellular responses, such as cell spreading or migration, requires the integrin cytoplasmic tails. These short tails bind to intracellular ligands that connect the receptors to signalling pathways and cytoskeletal networks. Hence, by binding both extracellular and intracellular ligands, integrins provide a transmembrane link for the bidirectional transmission of mechanical force and biochemical signals across the plasma membrane. One important mechanism by which cells regulate integrin function is through tight spatial and temporal control of integrin affinity for extracellular ligands. This is achieved by rapid, reversible changes in the conformation of the extracellular domains of the integrin heterodimer, so-called integrin activation3.

Functions
Proliferation: The mechanism by which integrins control proliferation involves both a direct crosstalk between integrins and growth factor receptors GFRs, and GF- independent signalling from integrins themselves. In some cells, for example, ERK signalling is induced directly by integrin adhesion, whereas the Akt pathway (which also promotes proliferation) can be activated downstream of integrins through mechanisms separate to those of GFRs4.

Apoptosis: Integrins are essential determinants of cell survival and, in many cases, prevention or alteration of integrin adhesion triggers a form of apoptosis that is known as anoikis. Anoikis is particularly relevant when cells become located in ECM environments in which they are not developmentally programmed to reside. For example, mammary epithelial cells are normally situated on a laminin-rich basement membrane but, if they are displaced to a stromal ECM of collagen I, they undergo anoikis5.

Differentiation: For some cell types, the involvement of integrins during their developmental programming to become fully mature, differentiated cells has been extensively characterized. Oligodendrocyte differentiation is a particularly neat example, because two integrin-GFR switches occur. In the first switch, PDGFaR collaborates with the vitronectin receptor avb3 integrin to promote proliferation of oligodendrocytes but, upon contact between cell processes and laminin-2, the same GFR (now in lipid rafts) works with a6b1 integrin to send survival signals. In the second switch, the EGF-family protein neuregulin sends survival and proliferation signals in oligodendrocyte precursors but, upon contact with laminin-2, the neuregulin receptors ErbB2 and ErbB4 provide signals that promote oligodendrocyte differentiation instead6.

Integrins control the cell-division axis: In studies conducted with conventional 2D tissue culture, cells divide in the plane of the dish to which they adhere, requiring alignment of the mitotic spindle parallel to the substratum (in the xy direction). Using micro-patterned ECM substrata that allow single cells to adhere with specific topologies, it has been shown that the tension exerted by the ECM (through integrin-containing adhesion) generates defined actin-cytoskeleton force fields within cells during interphase. During metaphase, cells round up to undergo mitosis, but retraction fibres transfer the polarity of tension that was established in interphase to the astral microtubules (which link the spindle poles with the cell cortex and, therefore, the plasma membrane), thereby aligning the mitotic spindle. Retraction fibres are bound to the substratum by integrins, so cell-matrix adhesion determines the internal architecture of cells, which subsequently defines the spindle position and, therefore, the division axis at mitosis7.

References

1.     Michishita, M, Videm, V. and Arnaout, MA (1993). A novel divalentcation binding site in the A domain of the a integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell., 72: 857-867.

2.     Lee OJ, Rieu, Arnaout MA and Liddington, R. (1995a). Crystal structure of the A-domain from the b ?subunit of the integrin CR3 (CD11a/CD18). Cell., 80: 631-638.

3.     Woodside DG, Liu S and Ginsberg MH (2001). Integrin activation. Thromb. Haemost., 86, 316-323.

4.     Velling T, Stefansson A and Johansson S (2008). EGFR and beta1 integrins utilize different signaling pathways to activate Akt. Exp. Cell Res., 314: 309-316.

5.     Pullan S, Wilson J, Metcalfe A, Edwards GM, Goberdhan N, Tilly J, Hickman JA, Dive C. and Streuli CH (1996). Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J. Cell Sci., 109: 631- 642.

6.     Baron W, Colognato H and ffrench-Constant C (2005). Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia., 49: 467- 479.

7.     Thery, M, Racine V, Pepin A, Piel M, Chen Y , Sibarita JB and Bornens M (2005). The extracellular matrix guides the orientation of the cell division axis. Nat. Cell Biol., 7: 947-953.

Raeber GP, et, al. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J. 2005 Aug; 89(2): 1374-88. : https://pubmed.ncbi.nlm.nih.gov/15923238/
Kraehenbuehl TP, et, al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials. 2008 Jun;29(18):2757-66. : https://pubmed.ncbi.nlm.nih.gov/18396331/

多肽Ac-Gly-Cys-Gly-Tyr-Gly-Arg-Gly-Asp-Ser-Pro-Gly-NH2的合成步骤：

1、合成MBHA树脂：取若干克MBHA树脂（如初始取代度为0.5mmol/g）和1倍树脂摩尔量的Fmoc-Linker-OH加入到反应器中，加入DMF，搅拌使氨基酸完全溶解。再加入树脂2倍量的DIEPA，搅拌混合均匀。再加入树脂0.95倍量的HBTU，搅拌混合均匀。反应3-4小时后，用DMF洗涤3次。用2倍树脂体积的10%乙酸酐/DMF 进行封端30分钟。然后再用DMF洗涤3次，甲醇洗涤2次，DCM洗涤2次，再用甲醇洗涤2次。真空干燥12小时以上，得到干燥的树脂{Fmoc-Linker-MHBA Resin}，测定取代度。这里测得取代度为 0.3mmol/g。结构如下图：

2、脱Fmoc：取1.52g的上述树脂，用DCM或DMF溶胀20分钟。用DMF洗涤2遍。加3倍树脂体积的20%Pip/DMF溶液，鼓氮气30分钟，然后2倍树脂体积的DMF 洗涤5次。得到 H2N-Linker-MBHA Resin 。（此步骤脱除Fmoc基团，茚三酮检测为蓝色，Pip为哌啶）。结构图如下：

3、缩合：取1.37mmol Fmoc-Gly-OH 氨基酸，加入到上述树脂里，加适当DMF溶解氨基酸，再依次加入2.74mmol DIPEA，1.3mmol HBTU。反应30分钟后，取小样洗涤，茚三酮检测为无色。用2倍树脂体积的DMF 洗涤3次树脂。（洗涤树脂，去掉残留溶剂，为下一步反应做准备）。得到Fmoc-Gly-Linker-MBHA Resin。氨基酸：DIPEA：HBTU：树脂=3：6：2.85：1（摩尔比）。结构图如下：

4、依次循环步骤二、步骤三，依次得到

H2N-Gly-Linker-MBHA Resin

Fmoc-Pro-Gly-Linker-MBHA Resin

H2N-Pro-Gly-Linker-MBHA Resin

Fmoc-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

H2N-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

Fmoc-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

H2N-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

Fmoc-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

H2N-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

Fmoc-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

H2N-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

Fmoc-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

H2N-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

Fmoc-Tyr(tBu)-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

H2N-Tyr(tBu)-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

Fmoc-Gly-Tyr(tBu)-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

H2N-Gly-Tyr(tBu)-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

Fmoc-Cys(Trt)-Gly-Tyr(tBu)-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

H2N-Cys(Trt)-Gly-Tyr(tBu)-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

Fmoc-Gly-Cys(Trt)-Gly-Tyr(tBu)-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin

以上中间结构，均可在专肽生物多肽计算器-多肽结构计算器中，一键画出。

最后再经过步骤二得到 H2N-Gly-Cys(Trt)-Gly-Tyr(tBu)-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHA Resin，结构如下：

5、乙酸酐反应连接：在上述树脂中，加入适当DMF后，再加入1.37mmol乙酸酐到树脂中，再加入2.74mmol DIPEA，鼓氮气反应30分钟。用2倍树脂体积的DMF 洗涤3次树脂（洗涤树脂，去掉残留溶剂，为下一步反应做准备）。 得到Ac-Gly-Cys(Trt)-Gly-Tyr(tBu)-Gly-Arg(Pbf)-Gly-Asp(OtBu)-Ser(tBu)-Pro-Gly-Linker-MBHAResin。 结构如下：

6、切割：6倍树脂体积的切割液（或每1g树脂加8ml左右的切割液），摇床摇晃 2小时，过滤掉树脂，用冰无水乙醚沉淀滤液，并用冰无水乙醚洗涤沉淀物3次，最后将沉淀物放真空干燥釜中，常温干燥24小试，得到粗品Ac-Gly-Cys-Gly-Tyr-Gly-Arg-Gly-Asp-Ser-Pro-Gly-NH2。结构图见产品结构图。

切割液选择：1）TFA：H2O=95%：5%

2）TFA：H2O：TIS=95%：2.5%：2.5%

3）三氟乙酸：茴香硫醚：1，2-乙二硫醇：苯酚：水=87.5%：5%：2.5%：2.5%：2.5%

（前两种适合没有容易氧化的氨基酸，例如Trp、Cys、Met。第三种适合几乎所有的序列。）

7、纯化冻干：使用液相色谱纯化，收集目标峰液体，进行冻干，获得蓬松的粉末状固体多肽。不过这时要取小样复测下纯度 是否目标纯度。

8、最后总结：

杭州专肽生物技术有限公司（ALLPEPTIDE https://www.allpeptide.com）主营定制多肽合成业务，提供各类长肽，短肽，环肽，提供各类修饰肽，如：荧光标记修饰（CY3、CY5、CY5.5、CY7、FAM、FITC、Rhodamine B、TAMRA等），功能基团修饰肽（叠氮、炔基、DBCO、DOTA、NOTA等），同位素标记肽（N15、C13），订书肽（Stapled Peptide）,脂肪酸修饰肽（Pal、Myr、Ste），磷酸化修饰肽（P-Ser、P-Thr、P-Tyr），环肽（酰胺键环肽、一对或者多对二硫键环），生物素标记肽，PEG修饰肽，甲基化修饰肽等。

以上所有内容，为专肽生物原创内容，请勿发布到其他网站上。